Medical

Medical

The antibody response against SARS-CoV-2 in patients pre- and post-infusion with commercial intravenous immunoglobulin products

Study: Commercial immunoglobulin products now contain neutralising antibodies against SARS-CoV-2 spike antibody which are detectable in patient Image Credit: Design_Cells/Shutterstock Background About the study Results Conclusion *Important notice No Byline Policy Editorial Guidelines Corrections Policy

Read More